Treatment options made for you

Ready for relief?

Explore your options and talk to your doctor about what may be right for you. Start your journey toward lasting relief.

Not sure where to start?

Consider what happens when the warning light in your car comes on. Would you replace the entire engine before investigating other solutions?

When you experience abnormal uterine bleeding (AUB) or symptomatic fibroids, your body is signaling that something needs attention. Relief may be possible through a number of treatment options, many of which are uterine-sparing.

Understanding your options empowers you to make informed decisions.

Better starts with you. Better starts here.

AUB Treatment Options

AUB relief starts here

Discover common AUB treatments, from least to most invasive.

Choosing the right care means understanding how your needs align with the available AUB treatment options. With a range of approaches, you and your healthcare provider can select the one that works best for you.

If your AUB is caused by fibroids, refer to the fibroid treatment section.

Contents

Non-invasive

Minimally-invasive

Invasive

Fibroid Treatment Options

Fibroid relief starts here

Explore common fibroid treatments, from least to most invasive.

Choosing the right care means understanding how your needs align with common fibroid treatment options. With a range of approaches, you and your healthcare provider can select the one that works best for you.

Contents

Non-invasive

Minimally-invasive

Invasive

Minimally-invasive solutions

Better starts here

Together with your doctor we can help make a better life your reality.

Historically, watchful waiting, medication and hysterectomies were the only solutions for treating abnormal uterine bleeding and fibroids. Now, there are minimally-invasive, uterine-sparing procedures that can provide relief with minimal downtime. 

NovaSure®
endometrial ablation

Reduce or eliminate heavy menstrual bleeding with a five-minute, non-hormonal procedure performed in your doctor’s office.6

Sonata®
fibroid ablation

Reduce fibroid symptoms and heavy menstrual bleeding with an incisionless, transcervical procedure to treat fibroids.15

Acessa®
fibroid ablation

Reduce fibroid symptoms and heavy menstrual bleeding with a minimally-invasive, laparoscopic procedure to treat fibroids.16

MyoSure®
tissue removal

Have polyps, fibroids or other tissue removed in approximately 15 minutes or less with a minimally-invasive procedure.17-21

Find a physician near you

Women wait on average 3.6 years before seeking treatment.22
Stop waiting. Better starts here.

Join our community

Women are often told pain and heavy bleeding are a normal part of their cycle. We know that’s not the case. Advocating for your health starts with knowing your body. We’re here to help you to take your first steps toward better.

Get to #KnowYourU (uterus) and find care that’s best for you!

*The recovery times listed are not from a single source comparing recovery times. The data listed comes from a variety of sources including clinical studies and recovery guidance
provided by major medical institutions.

MyoSure Manual is not indicated for the treatment of fibroids

Women with fibroids

References

  1. Abnormal Uterine Bleeding. ACOG. www.acog.org. https://www.acog.org/womens-health/faqs/abnormal-uterine-bleeding. Accessed October 2025.
  2. Intrauterine Device (IUD): Birth Control, Use & Side Effects. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/24441-intrauterine-device-iud. Accessed October 2025.
  3. What Is a D&C? Cleveland Clinic. https://my.clevelandclinic.org/health/procedures/dilation-and-curettage. Accessed October 2025.
  4. Hysteroscopy. Mount Sinai Health System, www.mountsinai.org/health-library/surgery/hysteroscopy. Accessed October 2025.
  5. Endometrial Ablation: What Is It, Side Effects & Recovery. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/21734-endometrial-ablation. Accessed October 2025.
  6. NovaSure Instructions for Use.
  7. What Is A Hysterectomy? Cleveland Clinic. https://my.clevelandclinic.org/health/procedures/hysterectomy. Accessed October 2025.
  8. Lykke R, Blaakaer J, Ottesen B, Gimbel H. Pelvic organ prolapse (POP) surgery among Danish women hysterectomized for benign conditions: age at hysterectomy, age at subsequent POP operation, and risk of POP after hysterectomy. Int Urogynecol J. 2015;26(4):527–532. doi: 10.1007/s00192-014-2490-y.
  9. The American College of Obstetricians and Gynecologists. (2022, July). Uterine Fibroids. www.acog.org. https://www.acog.org/womens-health/faqs/uterine-fibroids. Accessed October 2025.
  10. Myomectomy. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/15448-myomectomy. Accessed October 2025.
  11. Chudnoff S, Guido R, Roy K, Levine D, Mihalov L, Garza-Leal JG. Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas: The SONATA Trial. Obstet Gynecol. 2019 Jan; 133(1): 13-22s.
  12. Chudnoff SG, Berman J, Levine DJ, Harris M, Guido RS, Banks E. SG Chudnoff, et al. Outpatient Procedure for the Treatment and Relief of Symptomatic Uterine Myomas. Obstetrics and Gynecology, 2013;121(5):1075–82.
  13. Uterine Artery Embolization (UAE). Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/17954-uterine-artery-embolization. Accessed October 2025.
  14. Pron G; Mocarski E;Bennett J;Vilos G;Common A;Zaidi M;Sniderman K;Asch M;Kozak R;Simons M;Tran C;Kachura J; ; “Tolerance, Hospital Stay, and Recovery after Uterine Artery Embolization for Fibroids: The Ontario Uterine Fibroid Embolization Trial.” Journal of Vascular and Interventional Radiology : JVIR, U.S. National Library of Medicine, pubmed.ncbi.nlm.nih.gov/14551270/. Accessed 31 Aug. 2023.
  15. Sonata IFU.
  16. Acessa IFU.
  17. Hologic data on file, VER-04869.
  18. Hologic data on file, VER-13652.
  19. Hologic data on file, VER-11742.
  20. Hologic data on file, VER-11786
  21. Hologic data on file, VER-11576.
  22. Borah, Bijan J. et al. The impact of uterine leiomyomas: a national survey of affected women, American Journal of Obstetrics & Gynecology, October 2013, Volume 209, Issue 4, 319.e1—319.e20. Wise LA, Laughlin-Tommaso SK. Clin Obstet Gynecol. 2016;59(1):2-24. Alexander AL, et al. Obstet Gynecol. 2019;133(1):6-12.

Important Safety Information

The Acessa ProVu® system is intended to identify and shrink symptomatic uterine fibroids. The Acessa ProVu system is used by trained physicians during laparoscopic surgery under
general anesthesia. Rare but serious risks of this procedure include, but are not limited to, infection, internal injury, blood loss and complications related to laparoscopic surgery and/or
general anesthesia. This procedure is not recommended for women who are planning future pregnancy. This information is not medical advice. Please discuss the risks and benefits with your doctor to find out if the Acessa procedure may be right for you.

The MyoSure® tissue removal system is intended to remove unwanted tissue from the uterus. During a MyoSure procedure, a trained gynecologist inserts the MyoSure device through your vagina and then removes the unwanted tissue from inside the uterus. Use of the MyoSure system is not appropriate for patients who are or may be pregnant, or have signs or symptoms of a pelvic infection, cervical cancer, or previously diagnosed uterine cancer. As with any surgical procedure, there are potential risks including but not limited to internal injury, excessive bleeding, and complications related to anesthesia. Temporary side effects may include cramping, bleeding, fever, and nausea. This information is not medical advice. Please discuss the risks and benefits with your doctor to find out if the MyoSure procedure may be right for you.

NovaSure® endometrial ablation is for premenopausal women with heavy periods due to benign causes who are finished childbearing. Pregnancy following the NovaSure procedure can be dangerous. The NovaSure procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. NovaSure endometrial ablation is not a sterilization procedure. Rare but serious risks include, but are not limited to, thermal injury, perforation and infection. Temporary side effects may include cramping, nausea, vomiting, discharge and spotting. Inform patients to contact you if they experience a possible side effect related to use of this product. If you or someone you know has possibly experienced a side effect when using our product, please contact your physician.

The Sonata System is intended for diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, including those associated with heavy menstrual bleeding. Common Side Effects include bleeding, spotting, cramping, and/or discharge. There are potential risks with this treatment such as skin burn and infection. Women who are pregnant, have a pelvic infection, are known or suspected to have gynecologic cancer, or have intratubal implants for sterilization should not have this procedure